Sign inGet started

Flynn Patrick John

Insider CIK 1864871 · NRXP Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NRXP NRX Pharmaceuticals, Inc. A Award deriv2025-04-092025-09-1050,000— $050,000SEC↗
NRXP NRX Pharmaceuticals, Inc. P Buy2022-11-282022-11-292,500$1.25 $3.1K37,709SEC↗
NRXP NRX Pharmaceuticals, Inc. P Buy2022-11-282022-11-292,500$1.25 $3.1K37,709SEC↗
NRXP NRX Pharmaceuticals, Inc. P Buy2022-11-282022-11-292,500$1.24 $3.1K40,209SEC↗
NRXP NRX Pharmaceuticals, Inc. P Buy2022-11-282022-11-291,750$1.25 $2.2K1,750SEC↗
NRXP NRX Pharmaceuticals, Inc. P Buy2022-11-282022-11-292,500$1.25 $3.1K40,209SEC↗
NRXP NRX Pharmaceuticals, Inc. A Award deriv2022-10-212022-11-22162,660— $0162,660SEC↗
NRXP NRX Pharmaceuticals, Inc. A Award deriv2021-05-242021-06-10692,639— $0692,639SEC↗
NRXP NRX Pharmaceuticals, Inc. A Award deriv2021-05-242021-06-10692,639— $0692,639SEC↗
NRXP NRX Pharmaceuticals, Inc. A Award2021-05-242021-06-10362,332— $0362,332SEC↗
NRXP NRX Pharmaceuticals, Inc. A Award2021-05-242021-06-1035,209— $035,209SEC↗
NRXP NRX Pharmaceuticals, Inc. A Award2021-05-242021-06-1035,209— $035,209SEC↗